Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention.
Limburg PJ, Mahoney MR, Ziegler KL, Sontag SJ, Schoen RE, Benya R, Lawson MJ, Weinberg DS, Stoffel E, Chiorean M, Heigh R, Levine J, Della'Zanna G, Rodriguez L, Richmond E, Gostout C, Mandrekar SJ, Smyrk TC; Cancer Prevention Network. Limburg PJ, et al. Among authors: lawson mj. Cancer Prev Res (Phila). 2011 Feb;4(2):259-69. doi: 10.1158/1940-6207.CAPR-10-0215. Epub 2011 Jan 5. Cancer Prev Res (Phila). 2011. PMID: 21209397 Free PMC article. Clinical Trial.
A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index.
Zell JA, McLaren CE, Morgan TR, Lawson MJ, Rezk S, Albers CG, Chen WP, Carmichael JC, Chung J, Richmond E, Rodriguez LM, Szabo E, Ford LG, Pollak MN, Meyskens FL. Zell JA, et al. Among authors: lawson mj. Cancer Prev Res (Phila). 2020 Feb;13(2):203-212. doi: 10.1158/1940-6207.CAPR-18-0262. Epub 2019 Dec 9. Cancer Prev Res (Phila). 2020. PMID: 31818851 Free PMC article. Clinical Trial.
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.
Meyskens FL Jr, McLaren CE, Pelot D, Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, Albers CG, Ahnen DJ, Turgeon DK, Goldschmid S, Lance P, Hagedorn CH, Gillen DL, Gerner EW. Meyskens FL Jr, et al. Among authors: lawson mj. Cancer Prev Res (Phila). 2008 Jun;1(1):32-8. doi: 10.1158/1940-6207.CAPR-08-0042. Cancer Prev Res (Phila). 2008. PMID: 18841250 Free PMC article. Clinical Trial.
Stool DNA and occult blood testing for screen detection of colorectal neoplasia.
Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL. Ahlquist DA, et al. Among authors: lawson mj. Ann Intern Med. 2008 Oct 7;149(7):441-50, W81. doi: 10.7326/0003-4819-149-7-200810070-00004. Ann Intern Med. 2008. PMID: 18838724 Free PMC article. Clinical Trial.
The evolution to stool DNA testing for colorectal cancer.
Tagore KS, Levin TR, Lawson MJ. Tagore KS, et al. Among authors: lawson mj. Aliment Pharmacol Ther. 2004 Jun 15;19(12):1225-33. doi: 10.1111/j.1365-2036.2004.02005.x. Aliment Pharmacol Ther. 2004. PMID: 15191503 Free article. Review.
An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise?
McShane LM, Kulldorff M, Wargovich MJ, Woods C, Purewal M, Freedman LS, Corle DK, Burt RW, Mateski DJ, Lawson M, Lanza E, O'Brien B, Lake W Jr, Moler J, Schatzkin A. McShane LM, et al. Among authors: lawson m. Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):605-12. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9681529 Clinical Trial.
111 results